SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Nuvelo(NUVO)
An SI Board Since January 2004
Posts SubjectMarks Bans Symbol
140 19 0 NUVO
Emcee:  Arthur Radley Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
140Anyone know of any reason for hope NUVO?steve kammerer-12/30/2008
139Sonoma-3 fails, prompting NUVO to throw Alfimeprase overboard along with 40 empltuck-3/17/2008
138And the CEO is getting a salary of $800,000.00. I always said that rNAPc2 was a Arthur Radley-8/2/2007
137>>Nuvelo Reduces Expenses and Realigns Organization To Focus on Programs Etuck-8/2/2007
136<i>I expect another shoe to drop in the near future!! And Bayer dropping oDewDiligence_on_SI-6/26/2007
135Zebra’s Law (eom).DewDiligence_on_SI-6/26/2007
134Bayer bails (though it can opt back in), and NUVO goes on with alfimeprase: >tuck-6/26/2007
133NUVO has been lately publishing rNAPc2 results that don't add much to old datuck-6/22/2007
132Tuck...IMO a total grasping for straws with rNAPc2 in this indication. NUVO promArthur Radley-1/4/2007
131>>Nuvelo Initiates Phase 2 Trial of rNAPc2 in Patients with Metastatic Coltuck-1/4/2007
130thelindsayreport.comArthur Radley-12/24/2006
129<i>>What do the catheter results say about the drug's ability to diDewDiligence_on_SI-12/12/2006
128Tuck, This one hurts!Luckily I had followed a basic rule of taking some off the Arthur Radley-12/12/2006
127I would have no clue. nuvo ceo has been clever though, he already rescued them orkrw-12/12/2006
126Color from Bloomberg, courtesy of spartex at IHub, with analyst comments on rematuck-12/12/2006
125Sorry to raise the fur on your back, my mistake. :)rkrw-12/11/2006
124??? IDIX’s pipeline came out of academia.DewDiligence_on_SI-12/11/2006
123Good point. I wonder how many bio throwaways made it? Probably not all that manyrkrw-12/11/2006
122"all were big pharma throwaways" Maybe that's it. Be less skeptituck-12/11/2006
121Not saying rNAPc2 is the ticket, it's probably not. I think it may have beenrkrw-12/11/2006
120Perhaps CIBC are trying to defend whatever is left from one of their picks. The idos-12/11/2006
119<i>I'm not sure what NUVO thought they saw [with rNAPc2] that could reDewDiligence_on_SI-12/11/2006
118rNAPc2 is one of those molecules that has been kicked around from biotech to biotuck-12/11/2006
117Here is CIBC's answer,they and shares are appropriately valued in the $5 ranidos-12/11/2006
116Too bad for Ted Love, who seems like a nice guy. He was almost crying on the CC.DewDiligence_on_SI-12/11/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News